Clinical Evidence of Reduced Hemolysis with Butterfly Needles

, by Andrew Odgers, 14 min reading time

Clinical Evidence

Clinical Evidence: Studies Showing Reduced Haemolysis with Butterfly Needles

Haemolysis is one of the leading causes of rejected blood samples and repeated venepuncture. A growing body of clinical research demonstrates that butterfly needles consistently produce lower haemolysis rates than straight needles, particularly in patients with difficult vein access. This guide summarises the evidence, explains the mechanism, and draws out the practical implications for procurement and clinical practice.

UpdatedMay 2026
Written byCharles Medical Team
Reading time7 min
Understanding the problem

What is haemolysis and why does it matter?


The mechanism of haemolysis

Haemolysis is the rupture of red blood cells, which releases haemoglobin and intracellular contents into the plasma. When it occurs during blood collection it is called pre-analytical haemolysis, meaning it happens before the sample reaches the laboratory analyser. The disrupted cells release potassium, lactate dehydrogenase, and other intracellular markers into the surrounding serum, altering the measured concentration of those analytes and making the results unreliable.

Haemolysis is detected visually as a pink or red tinge in the serum once the sample is centrifuged, or automatically by laboratory analysers that measure haemolysis index. Most laboratories have threshold values above which a sample is reported as haemolysed and rejected for some or all analytes.

The clinical and operational cost

A rejected haemolysed sample means the patient must be re-bled. In a busy phlebotomy service this has direct costs in staff time, consumables, and patient inconvenience. For inpatient or unwell patients, repeated venepuncture causes additional discomfort and can exhaust available vein access. For time-sensitive results such as potassium in acute kidney injury or troponin in chest pain, a haemolysed sample delays clinical decision-making.

Haemolysis rates of between 3 and 10 percent of all samples collected are commonly reported in hospital laboratories. Even at the lower end of this range, the cumulative cost across a large service is significant. Reducing haemolysis by even a few percentage points translates into fewer repeat collections, faster turnaround times, and lower overall cost per reportable result.

Causes of pre-analytical haemolysis

Multiple factors contribute to haemolysis during collection. Mechanical trauma to red cells caused by excessive force during aspiration, turbulent flow through a narrow lumen, a mismatch between needle gauge and the vacuum in the collection tube, and physical damage to the vein during needle insertion are all established causes. The choice of needle device is therefore one of several modifiable variables that affect haemolysis risk.

What the research shows

Evidence for lower haemolysis with butterfly needles


Emergency department and difficult access studies

The most consistent evidence for butterfly needle superiority comes from studies conducted in emergency departments and on populations with difficult vein access. These settings produce the highest haemolysis rates overall, and it is here that the difference between needle types is most pronounced.

Multiple published studies comparing winged infusion sets to straight needle vacutainer systems in emergency or acute care settings have found haemolysis rates that are substantially lower in the butterfly needle groups. Absolute reductions in haemolysis rates of between 3 and 8 percentage points have been reported in several controlled comparisons, with the effect most pronounced in collections from hand veins and in patients described as having difficult or fragile vein access.

A frequently cited mechanism is the lower shear force applied to red cells during collection with a butterfly needle. The flexible tubing and lower insertion angle reduce the turbulence experienced by blood as it enters the needle, and the wing grip allows more controlled advancement of the needle through the vein wall, causing less physical disruption to the vessel.

Inpatient and ward-based evidence

Studies conducted on general ward patients show a smaller but still consistent reduction in haemolysis with butterfly needles compared to straight needles. The effect is less dramatic in this population because ward patients as a group tend to have better vein access than emergency department patients, and the relative advantage of the butterfly needle design is therefore less pronounced.

However, several ward-based studies have identified specific subpopulations where the difference is clinically significant. Elderly inpatients with age-related vein fragility, oncology patients whose veins have been compromised by previous treatment, and patients on long-term anticoagulation show substantially higher haemolysis rates with straight needles than with butterfly needles across multiple study populations.

Outpatient and phlebotomy clinic evidence

In routine outpatient phlebotomy on healthy adults with good antecubital vein access, the evidence for a meaningful haemolysis difference between needle types is weaker. Several studies in this setting have found no statistically significant difference in haemolysis rates between the two device types when operator technique is controlled. This is consistent with the mechanistic understanding that the advantages of the butterfly needle are most relevant when vein access is difficult and the risk of mechanical trauma is higher.

The practical implication is that butterfly needles do not universally produce lower haemolysis in all patient populations. They provide the greatest benefit in the patients who are at highest risk of haemolysis in the first place.

Gauge selection and haemolysis

Within both needle types, gauge is an independent variable affecting haemolysis risk. Narrower gauges produce more turbulent flow relative to the vacuum of the collection tube, increasing red cell shear. This effect is amplified when a narrow gauge needle is used with a standard adult vacutainer tube, whose vacuum is designed for faster collection rates than a 25 gauge needle can provide.

The solution is to match gauge to the collection tube size. When using a 25 gauge butterfly needle, collecting into smaller paediatric tubes reduces the effective vacuum and lowers haemolysis risk substantially. This paediatric tube technique is well-established practice in neonatal and difficult-access collections using butterfly needles.

Practical takeaways

What the evidence means for clinical practice


The research points to clear, actionable conclusions for procurement decisions and daily technique.

  • Use butterfly needles for all hand and foot vein collections. The evidence for reduced haemolysis is strongest in these locations, and the flexible tubing provides additional protection against movement-related trauma.
  • Prioritise butterfly needles for elderly patients and those with fragile veins. Age-related vein fragility is one of the most consistent predictors of haemolysis, and butterfly needles demonstrably reduce this risk in this population.
  • Use paediatric tubes with 25 gauge butterfly needles. Mismatching a narrow gauge needle with a high-vacuum adult tube is a preventable cause of haemolysis. Using smaller tubes eliminates the vacuum mismatch.
  • Do not skip the discard tube. Air in the butterfly needle tubing is itself a cause of haemolysis in the first diagnostic tube. The discard step is a haemolysis prevention measure, not just a protocol formality.
  • Audit haemolysis rates by collection method and patient group. Services that track haemolysis by device type and patient category consistently identify the highest-risk populations where switching to butterfly needles produces measurable quality improvement.
  • Factor repeat collection costs into procurement decisions. The higher unit cost of butterfly needles is partly or fully offset by lower repeat collection rates in high-risk populations. Total cost per reportable result is the relevant metric, not unit device cost alone.
Reduce rejections

Lower haemolysis starts with the right needle

Charles Medical supplies butterfly needles with integrated safety mechanisms across all clinical gauges. Order in unit or bulk quantities with next-day UK delivery.

For a full comparison of device types across all clinical scenarios, see Butterfly Needles vs Straight Needles: Pros, Cons and When to Use Each.

Part of the hub

Back to the Butterfly Needle Knowledge Hub

This article is part of our complete butterfly needle knowledge base, covering clinical use, gauge selection, technique, haemolysis reduction, cost analysis, patient guidance, and the full regulatory picture for UK procurement.

Keep reading

Related guides in this hub


How Butterfly Needles Help in Reducing Complications in Blood Sample Collection covers haematoma, failed attempts, and patient discomfort alongside haemolysis. How Clinics Can Reduce Sample Rejection Rates by Using Butterfly Needles translates the evidence into an operational quality improvement framework. And Cost Analysis: Are Butterfly Needles Worth the Investment works through the financial case in detail.

Frequently asked

Haemolysis and butterfly needle questions answered


Do butterfly needles always cause less haemolysis?
Not in every patient population. The evidence is strongest in patients with difficult or fragile vein access, including elderly patients, emergency department patients, and those with hand or foot vein collections. In routine outpatient collections from good antecubital veins in healthy adults, the difference in haemolysis rates between butterfly and straight needles is smaller and not always statistically significant.
What causes haemolysis during blood collection?
The main causes are mechanical trauma to red cells during collection. This includes excessive aspiration force, turbulent flow through a narrow gauge needle, a mismatch between needle gauge and tube vacuum, physical disruption of the vein wall during insertion, and air in the collection tubing. Each of these is influenced by the choice of device and collection technique.
Why does skipping the discard tube cause haemolysis?
The flexible tubing of a butterfly needle contains a small volume of air. If this air enters the first collection tube it mixes with the blood sample and can rupture red cells or interfere with tube additives. Collecting a discard tube first fills the tubing completely with blood before the diagnostic sample is drawn, eliminating the air-blood interface that causes this problem.
Which gauge butterfly needle produces the least haemolysis?
The widest gauge that the patient's vein can comfortably accommodate produces the least haemolysis. A 21 gauge needle allows faster, less turbulent flow than a 23 or 25 gauge needle, reducing shear stress on red cells. When using narrower gauges such as 25 gauge, collecting into smaller paediatric tubes rather than standard adult vacutainer tubes reduces the vacuum mismatch that contributes to haemolysis at low flow rates.
How do I measure whether switching to butterfly needles reduces haemolysis in my service?
Track haemolysis rates from your laboratory information system stratified by collection device, collection site, and patient group. Run a controlled period using butterfly needles on your highest-risk cohort while continuing standard practice elsewhere, then compare rejection rates between groups. Most laboratory quality improvement frameworks include haemolysis rate as a standard pre-analytical quality indicator.

Blog posts

© 2026 Charles Medical, Powered by Shopify

  • American Express
  • Apple Pay
  • Diners Club
  • Discover
  • Google Pay
  • Klarna
  • Maestro
  • Mastercard
  • Shop Pay
  • Union Pay
  • Visa

Login

Forgot your password?

Don't have an account yet?
Create account